Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 10% | 8.2% | 15.1% |
| Success rate | 87% | 68% | 82% |
| Transactions |
12
100% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Independent Chairman of the Board | BioXcel Therapeutics Inc | April 1, 2017 - |
| President of R&D and Chief Scientific Officer | Axcella Health Inc | None - |
| Executive Vice President - Global Research and Development, Chief Scientific Officer | Vertex Pharmaceuticals Inc | May 15, 2009 - Oct. 31, 2014 |
Search